Site Map

• Home

• About GEP-NET Patients

  About GEP-NET Patients

  • The Frequency of GEP-NETs
  • Early Action Can Be Critical
  • Disease Progression
  • Role of SSTR
  • Identifying Patients for LUTATHERA

• Efficacy

  Efficacy

  • Efficacy Across Clinical Trials
  • LUTATHERA in Newly Diagnosed Patients
  • LUTATHERA After SSA Progression
  • PROs Across Clinical Trials

• Safety

  Safety

  • Long-Term Safety
  • NETTER-2 Safety Profile
  • NETTER-1 Safety Profile
  • Radiation Safety and Counseling

• Dosing and Administration

  Dosing and Administration

  • Dosing Schedule
  • Preparing and Administering LUTATHERA
  • Dose Modifications

• Novartis Patient Support

  Novartis Patient Support

  • Novartis Patient Support
  • Product Ordering

• Resources

  Resources

  • LUTATHERA Treatment Sites
  • Health Care Professional Resources
  • Patient Resources